{"id":"NCT01361607","sponsor":"Jazz Pharmaceuticals","briefTitle":"Sativex速 for Relieving Persistent Pain in Patients With Advanced Cancer","officialTitle":"A Double Blind, Randomized, Placebo-controlled, Parallel Group Study of Sativex Oromucosal Spray (Sativex速; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05-27","primaryCompletion":"2014-11-24","completion":"2014-11-24","firstPosted":"2011-05-27","resultsPosted":"2018-04-23","lastUpdate":"2023-04-12"},"enrollment":399,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Advanced Cancer"],"interventions":[{"type":"DRUG","name":"Nabiximols","otherNames":["Sativex速"]},{"type":"DRUG","name":"Placebo (GA-0034)","otherNames":[]}],"arms":[{"label":"Nabiximols","type":"EXPERIMENTAL"},{"label":"Placebo (GA-0034)","type":"PLACEBO_COMPARATOR"}],"summary":"This 9-week study aimed to determine the efficacy, safety, and tolerability of nabiximols (Sativex速) as an adjunctive treatment, compared with placebo in relieving uncontrolled persistent chronic pain in participants with advanced cancer.\n\nEligible participants were not required to stop any of their current treatments or medications.","primaryOutcome":{"measure":"Percent Improvement From Baseline In Mean NRS Average Pain At End Of Treatment","timeFrame":"Baseline, End of Treatment (Day 36)","effectByArm":[{"arm":"Nabiximols","deltaMin":7.2,"sd":null},{"arm":"Placebo (GA-0034)","deltaMin":9.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2735"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":68,"countries":["United States","Bulgaria","Czechia","Germany","Hungary","Mexico","Poland","Puerto Rico","Romania","United Kingdom"]},"refs":{"pmids":["28785408"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":199},"commonTop":["Nausea","Somnolence","Vomiting","Dizziness","Constipation"]}}